Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Profit After Tax (2019 - 2025)

IDEAYA Biosciences' Profit After Tax history spans 7 years, with the latest figure at -$83.3 million for Q4 2025.

  • For Q4 2025, Profit After Tax rose 36.1% year-over-year to -$83.3 million; the TTM value through Dec 2025 reached -$113.7 million, up 58.58%, while the annual FY2025 figure was -$113.7 million, 58.58% up from the prior year.
  • Profit After Tax for Q4 2025 was -$83.3 million at IDEAYA Biosciences, down from $119.2 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $119.2 million in Q3 2025 and bottomed at -$130.3 million in Q4 2024.
  • The 5-year median for Profit After Tax is -$25.8 million (2022), against an average of -$30.5 million.
  • The largest annual shift saw Profit After Tax crashed 1799.07% in 2023 before it surged 330.11% in 2025.
  • A 5-year view of Profit After Tax shows it stood at -$18.2 million in 2021, then plummeted by 32.88% to -$24.2 million in 2022, then plummeted by 40.3% to -$34.0 million in 2023, then tumbled by 283.78% to -$130.3 million in 2024, then surged by 36.1% to -$83.3 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Profit After Tax are -$83.3 million (Q4 2025), $119.2 million (Q3 2025), and -$77.5 million (Q2 2025).